Research shows that patients using the myAir software platform significantly improve in their daily CPAP usage and adherence to sleep therapy. The technology it employs empowers patients to track and understand their therapy, receive daily and periodical reports, and consult educational and self-help tools and videos for additional support. myAir is designed to motivate patients by tracking their sleep data and coaching them through a personalised programme tailored to their specific needs and sleep patterns.
ResMed’s innovative technology that underlies its software platforms benefits patients, as well as healthcare professionals.
Tell us about the technology behind the devices. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for our healthcare systems. These platforms allow remote monitoring and effective management of symptoms and conditions which can be responded to in real time, without the need for in-person appointments or prolonged stays in hospital. Utilising cloud-connected technology and enabling remote care pathways help to relieve pressure on care systems through software platforms. Our devices went digital in 2014, optimising our offering and giving greater freedom and flexibility to patients and caregivers alike. Fast forward eight years, Dr Peter Farrell founded ResMed and bought Sullivan’s sleep technology, commercialising his prototype CPAP device and bringing the device to the mainstream market, which led to ResMed as we know it today. Our story begins in 1981, when Professor Colin Sullivan and colleagues at the University of Sydney developed Continuous Positive Airway Pressure (CPAP), a successful non-invasive treatment for obstructive sleep apnoea (OSA).
0 kommentar(er)
